Abstract A 3½ year old girl presented with failure to thrive and a five month history of diarrhoea and recurrent cough.
Introduction
The diagnosis of cystic fibrosis in a child often depends on the clinical features of failure to thrive and recurrent respiratory infections along with the laboratory findings of abnormal sweat electrolyte concentrations. We have recently assessed a child with such clinical and laboratory findings who had a final diagnosis of symptomatic human immunodeficiency virus (HIV) infection.
Case report
A 3½1/ year old girl presented with a five month history of diarrhoea, recurrent cough, and failure to thrive. She was the second of four children whose ages ranged from 4 months to 6 years. The parents were nonconsanguinlous and the mother had received a blood transfusion after the birth ofthe eldest child. The child herselfhad never received blood or blood products. Our patient was admitted to hospital because of exacerbation of her cough. During the three months before diagnosis she had had several episodes of fever and cough and showed both clinical and radiological changes of bronchopneumonia. She was also failing to thrive, her weight falling from the 50th centile at the age of 1½/2 years to less than the third centile at the time of the initial assessment.
Bacteriological investigation showed her sputum to be growing Her IgG, IgA, and IgM concentrations were all raised (290 IU/ml, 400 IU/ml, 600 IU/ml respectively.) She had a fluctuating white cell count and on several occasions had neutropenia, the lowest total white blood cell count being 2 9x109/l with lixl109/l neutrophils. The haemoglobin remained around 80 g/l and the platelet count was normal.
A repeat sweat sodium concentration was 108 mmol/kg, with a chloride concentration of 93 mmol/kg and weight of sweat of 156 mg. A further sample produced similar results. The child was started on pancreatic replacement therapy and given intensive physiotherapy and antibiotic treatment while awaiting the results oftests ofpolymorphonuclear leucocyte and T cell function. With this treatment there was no clinical improvement.
Fludrocortisone was then given orally for two days in a dose of 2 mg/m2
per day. A further sweat test showed a sweat sodium concentration of 31 mmol/kg and chloride concentration of24 mmol/kg with a weight ofsweat of 136 mg. Two weeks before diagnosis the child's condition deteriorated, with increasing respiratory problems, weight loss, and watery diarrhoea. Once again H injluenzae was grown from sputum along with C albicans. Serum tests for Pneumocystis carinii were negative. Once again she responded to antibiotic treatment guided by culture and sensitivity report.
The results of stool examtion were negative for cryptosporidium, Isospora belli, and atypical mycobacteria.
A preliminary report from the immunology department that the child's T4 lymphocytes were reduced greatly, along with the hyperglobulinaemia and neutropenia, prompted us to check the patient's blood for antibody to HIV. This was positive on ELISA (enzyme linked immunosorbent assay) testing and confirmed by Western blot technique. These tests were repeated and found to be consistent.
At that point treatment with high dose intravenous co-trimoxazole and zidovudine by mouth was started. Intravenous human immunoglobulin was given and she was discharged from hospital to continue that treatment. During the first two months after discharge the child remained in better health, gaining weight and having less diarrhoea and respiratory symptoms. Her peripheral blood white cell count dropped and zidovudine was stopped and the co-trimoxazole changed to another antibiotic, but after a month her condition deteriorated with further respiratory infections and weight loss.
She was restarted on zidovudine and at the time of writing was receiving immunoglobulin intravenously once every three weeks. Her condition was deteriorating, however, and she was being fed through a nasogastric tube.
Her 2 year old sister, who was also UI1V positive, had three episodes of pneumonia over the past year, H influenzae being isolated from gastric aspirate on the latest occasion. She also suffered weight loss, hyperglobulinaemia, and anaemia. Her sweat electrolyte concentrations were unequivocally normal. One other sibling, aged 9 months, and both parents were also HIV positive, but all were completely asymptomatic and had normal sweat test results.
Discussion
Many children present with frequent respiratory illnesses, and in the ones who are failing to thrive and who may also have diarrhoea a sweat test is usually performed to exclude or confirm cystic fibrosis. When the procedure is correctly performed it is generally accepted that a sweat sodium concentration of greater than 70 mmol/kg combined with that clinical picture suggests a diagnosis of cystic fibrosis. Other conditions, such as adrenal insufficiency, hypothyroidism, and diabetes insipidus, may be associated with abnormal sweat electrolyte concentrations, but our patient showed none of the clinical or biochemical features of any of these.
The use of fludrocortisone to suppress sweat electrolyte concentration was described in 1966, when Lobeck and McSherry observed that sweat sodium and chloride concentrations of patients with cystic fibrosis did not decrease if they were given large doses of 9 a-fludrocortisone.' In our child there was a clear response to this test.
Although H influenzae may be found in the sputum of children with cystic fibrosis, we were surprised that Staphylococcus aureus was not also isolated. Furthermore, C albicans is an unusual finding in children's sputum unless they have been receiving long term antibiotic treatment.
Diarrhoea and failure to thrive are common presenting features in children with symptomatic HIV infection.2 In our child the diarrhoea was not malabsorptive and did not respond to pancreatic replacement treatment. Organisms which may be suspected in this situation are protozoans such as cryptosporidium, microsporidia, and Isospora belli. A search should also be made for atypical mycobacteria, cytomegalovirus, and herpes simplex virus, any of which may cause a malabsorptive picture. Our patient had no evidence of any of these organisms or any evidence of neoplasia.
With the incidence ofcystic fibrosis in the community of 1 in 2000 it would not be surprising that a child with clear evidence of cystic fibrosis responding to standard treatment should be found to be HIV positive (personal communication, Dr J Mok, consultant paediatrician, City Hospital, Edinburgh). Although initially HIV positive this child has since become HIV negative, therefore suggesting clearing of maternal HIV antibody.
Measuring immunoreactive trypsin is not helpful as a diagnostic aid beyond the neonatal period, and gene probe analysis would not have been useful as there was no family history ofcystic fibrosis. We think that there is little doubt that our patient had not got cystic fibrosis.
We therefore suggest that children presenting with symptoms suggestive of cystic fibrosis but with atypical features such as unexpected bacteriological results, failure to respond to treatment, or hyperglobulinaemia should have both their sweat test result validated by a fludrocortisone suppression test and their HIV state checked. If the HIV test result is positive it will, as in our family, allow rationalisation of treatment and counselling for the family.
